Page 23 - Service Testing News Today

By Sabela Ojea Abbott Laboratories said it has received positive results from its chronic limb-threatening ischemia trial and it expects to submit the drug...

By Jeffrey T. Lewis MAIA Biotechnology's shares jumped 28% after the clinical stage company said a study of one of its cancer treatments showed positive...

Moderna Inc. investors enjoyed a rare rally Tuesday as the shares of the biotechnology company headed for their first gain in two weeks.

By Josh Beckerman Moderna said the first participant has been dosed in a Phase 3 study of mRNA-1083, its combination vaccine candidate against influenza and...

By Stuart Condie SYDNEY--Immutep shares are on course for their best day since June after the Australia-listed developer of cancer treatments presented...

By Anthony O. Goriainoff NetScientific said that its portfolio company PDS Biotechnology announced data from the phase 2 clinical trial evaluating the safety...

Eli Lilly’s retatrutide will be in clinical trials for the next three years, but knockoff versions already abound

By Will Feuer Evelo Biosciences said it is reviewing strategic alternatives after its Phase 2 clinical trial of EDP2939 for the treatment of moderate...

By Josh Beckerman Evelo Biosciences shares fell 58% as the company said it will discontinue EDP2939 after a Phase 2 study in moderate psoriasis didn't meet...

By Will Feuer Omeros said it is discontinuing its late-stage clinical trial evaluating its narsoplimab drug for the treatment of immunoglobulin A nephropathy...